Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
N4 Pharma PLC (GB:N4P)
LSE:N4P
Holding GB:N4P?
Track your performance easily
N4P Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.37p - 1.47p
Previous Close0.6p
Volume267.21K
Average Volume (3M)1.46M
Market Cap
£6.51M
Enterprise Value5.55M
Total Cash (Recent Filing)£1.03M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Feb 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding394,780,000
10 Day Avg. Volume1,103,407
30 Day Avg. Volume1,463,162
Standard Deviation0.26
R-Squared0.04
Alpha0.00696
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1212.84
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
N4 Pharma News
PremiumCompany Announcements
N4 Pharma’s New Patent Targets IBD TreatmentPremiumCompany Announcements
N4 Pharma Grants 15 Million Options to Key Directors
PremiumCompany Announcements
N4 Pharma Engages Investors with CEO Q&A SessionPremiumCompany Announcements
N4 Pharma Showcases Strategic Focus and Growth Plans
PremiumCompany Announcements
N4 Pharma Advances in Vaccine and Cancer Delivery
PremiumCompany Announcements
N4 Pharma Reports Progress in Gene Delivery Tech
PremiumCompany Announcements
N4 Pharma Welcomes New Board ExpertiseN4P FAQ
What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.36p and its highest was 1.47p in the past 12 months.
What is N4 Pharma PLC’s market cap?
Currently, no data Available
When is N4 Pharma PLC’s upcoming earnings report date?
N4 Pharma PLC’s upcoming earnings report date is Feb 19, 2025 which is in 59 days.
How were N4 Pharma PLC’s earnings last quarter?
N4 Pharma PLC released its earnings results on Sep 24, 2024. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is N4 Pharma PLC overvalued?
According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued.
Does N4 Pharma PLC pay dividends?
N4 Pharma PLC does not currently pay dividends.
What is N4 Pharma PLC’s EPS estimate?
N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma PLC have?
N4 Pharma PLC has 394,780,330 shares outstanding.
What happened to N4 Pharma PLC’s price movement after its last earnings report?
N4 Pharma PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of N4 Pharma PLC?
Currently, no hedge funds are holding shares in GB:N4P
---
N4 Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.41%
12-Months-Change
Fundamentals
Return on Equity
-79.99%
Trailing 12-Months
Asset Growth
-10.94%
Trailing 12-Months
Company Description
N4 Pharma PLC
N4 Pharma PLC is a United Kingdom-based specialist pharmaceutical company. The company is engaged in reformulating existing drugs and vaccines to improve their performance to benefit the patients. The group operates in one business segment, that of the development and commercialization of medicines via its delivery system called Nuvec.
---
Technical Analysis
---